Study tracks changes in NF2 using repeated brain scans
Part of Brain & nervous system, Cancer, Ear, nose & throat, Genetic & congenital clinical trials.
This study follows people with neurofibromatosis type 2 (NF2) over time to learn how the condition changes, using repeat MRI scans. The information may help researchers understand disease patterns and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of NF2 (by doctor criteria or genetic test).
- Your age is between 8 and 75.
- You can have repeated MRI scans of your brain/spine without needing IV sedation.
- You (or your parent/guardian, if you’re a child) can understand the study and agree to participate.
- You can safely have MRI with the clinic’s equipment and rules (no unsafe metal implants/clips, and no MRI allergy that prevents scanning).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information about adults in Russia with Neurofibromatosis type 1 who have symptomatic plexiform neurofibromas and have not yet been treated with a MEK inhibitor. It aims to better understand the condition and its treatment in real-world settings.
This study tracks people with NF1 to watch for when benign nerve tumors turn cancerous. It uses regular MRI scans to catch changes early, which could help guide treatment decisions.
This study talks with people who have NF1 (and caregivers of children with NF1) about how visible tumors affect them. The goal is to create questionnaires that measure these concerns, which could lead to better support and treatments.
This study uses MRI scans to check and improve how medical teams measure brain changes. If you’re eligible, you’ll complete MRI safety screening and imaging while the team studies which scan measurements work best.
This study looks at how multiple sclerosis (MS) affects MRI scans and other measurements in the brain, spinal cord, and eyes. It may help researchers better understand MS changes over time, using follow-up visits and, in the future, donated tissue after death.
This study checks whether patient surveys (questionnaires) can reliably measure symptoms and pain in people with NF1 who have plexiform neurofibromas. It helps create better tools for tracking how you feel and how treatments may affect quality of life.
Hear when a new Neurofibromatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.